Showing results (2291-2300 of 2,776) with videos related to

Sort By:
Pageof 278
Bioanalysis|August 9, 2019
Development and application of a urine drug concentration method for the evaluation of oral absorption of ibandronate in clinical patientsJing An, Ye Jiang, Yanfang Lu, et al.
Bioanalysis|August 9, 2019
The 10th Japan Bioanalysis Forum Symposium conference: a reportYoshihisa Sano, Yoshiaki Ohtsu, Harue Igarashi, et al.
Bioanalysis|September 27, 2019
Variations in internal standard response: some thoughts and real-life casesOlivier Le Blaye
Bioanalysis|October 1, 2019
GCC Consolidated Feedback to ICH on the 2019 ICH M10 Bioanalytical Method Validation Draft GuidelineCorey Nehls, Michael Buonarati, Stephanie Cape, et al.
Bioanalysis|October 1, 2019
Very complex internal standard response variation in LC-MS/MS bioanalysis: root cause analysis and impact assessmentNico C van de Merbel, Remco A Koster, Corey Ohnmacht
Bioanalysis|September 4, 2019
CX1003 quantification by ultra-performance LC-MS/MS in human plasma and its application to a pharmacokinetic study in solid tumor patientsYu Li, Qian Zhao, Pei Hu, et al.
Bioanalysis|November 11, 2021
Quantitation of reduced IL-33 levels in human serum: mitigating interference from endogenous binding partnersJoshua Zylstra, Michael A Partridge, Giane Sumner
Bioanalysis|March 16, 2019
High sensitivity methods to quantify chloroquine and its metabolite in human blood samples using LC-MS/MSKarnrawee Kaewkhao, Kesinee Chotivanich, Markus Winterberg, et al.
Bioanalysis|March 16, 2019
Determination of sofosbuvir with two co-administered drugs; paracetamol and DL-methionine by two chromatographic methods. Application to a pharmacokinetic studyMichel Y Fares, Nada S Abdelwahab, Maha M Abdelrahman, et al.
Bioanalysis|August 6, 2019
Optimized UPLC-MS/MS method for the quantitation of olanzapine in human plasma: application to a bioequivalence studyPing Du, Pengfei Li, Rui Zhao, et al.
Pageof 278